Skip to main content
. 2022 Aug 1;33(8):682–688. doi: 10.5152/tjg.2022.21375

Supplementary Table 1.

Subgroup Analysis Depending on Disease Duration (Longer than 3 Years)

Patient-reported outcomes UCEIS 0-1 (N = 25) UCEIS 2-8 (N = 42) P
Basic
 Stool frequency, n (%) 19 (76.0%) 13 (31.0%) .001
+ 6 (24.0%) 29 (69.0%)
 Rectal bleeding, n (%) 24 (96.0%) 16 (38.1%) <.001
+ 1 (4.0%) 26 (61.9%)
Additional
 Urgency, n (%) 20 (80.0%) 18 (42.9%) .007
+ 5 (20.0%) 24 (57.1%)
 Tenesmus, n (%) 22 (88.0%) 17 (40.5%) <.001
+ 3 (12.0%) 25 (59.5%)
 Mucoid stool, n (%) 23 (92.0%) 23 (54.8%) .004
+ 2 (8.0%) 19 (45.2%)
 Night defecation, n (%) 24 (96.0%) 30 (71.4%) .032
+ 1 (4.0%) 12 (28.6%)
Clinical remission1 + 18 (72.0%) 8 (19.0%) <.001
7 (28.0%) 34 (81.0%)
Additional 4 PROs2 0 19 (76.0%) 11 (26.2%) <.001
≥1 6 (24.0%) 31 (73.8%)

1Clinical remission defined as stool frequency 0 and rectal bleeding 0

2Additional 4 PROs defined as summation of urgency, tenesmus, mucoid stool, and night defecation.